Dulles, VA  (March 31, 2025) – Today, SOFIE Biosciences, a leader in radiopharmaceuticals, announces the opening of a PET Manufacturing and Radiopharmacy facility in Decatur, Illinois. This site activation strengthens SOFIE’s production and distribution network, allowing the company to expand its service across Illinois, Missouri, and Indiana. Patient dose delivery will begin this week.

“We are excited to integrate this facility into our growing network,” said Mike Parisi, Vice President, Sales & Marketing at SOFIE. “This expansion enhances our ability to deliver high-quality PET radiopharmaceuticals to healthcare providers and patients across the region, supporting better diagnostic and therapeutic outcomes.”

The newly acquired facility will operate under SOFIE’s rigorous quality and compliance standards while maintaining uninterrupted service to existing customers. This acquisition reflects SOFIE’s commitment to advancing molecular imaging and nuclear medicine through expanded access and innovation.

About Sofie Biosciences:

SOFIE’s vision is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (Theranostics). With its robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value Theranostic intellectual property, SOFIE is poised to deliver on the promise of radiopharmaceuticals. For more information, please visit https://sofie.com or contact us.